Artificial-Intelligence Enabled Solution


As on May 2022


new sites finalized
in Maharashtra for
qXR software deployment


existing sites reactivated
for further deployment
of qXR

Geographical Focus
  • PAN India
Potential Impact
  • Interpret


    chest scans across


    health sites

Samridh support

SAMRIDH is supporting Qure.ai to scale qXR, an AI-enabled chess X-ray solution, to 50 sites across India, allowing them to provide an estimated 62,500 chest scans over a period of 12 months. With this support, Qure.ai is empowering frontline health workers to make rapid patient management decisions pertaining to COVID-19 and TB screening services with its software technology, qXR. Moreover, the financial assistance from SAMRIDH has enabled Qure.ai to raise commercial capital in the form of equity and debt for further expansion of their solution..


of COVID-19 tests in India are rapid antigen tests[1]


CB-NAAT machines available in India to detect lung diseases like TB

Testing and tracking on a large scale is an essential public health response to deal with highly infectious diseases like Tuberculosis (TB) and COVID-19. Rapid antigen tests and X-ray solutions can help detect these infections and produce quick results. However, India faced a severe shortage of testing supplies and medical devices during the COVID-19 pandemic. This adversely impacted the ability of hospitals and health workers in low-resource settings to monitor and extend timely appropriate treatment to patients.

Strengthening healthcare infrastructure using AI algorithm for chest X-rays

qXR, is an AI-enabled chest X-ray solution by Qure.ai, that can identify up to 30 distinct lung abnormalities in under a minute. The qXR solution can be used by healthcare workers to identify, prioritize, and reduce the transmission of highly communicable diseases. Qure.ai is utilizing qXR to identify findings related to COVID-19 infections and use it as a triage tool in settings with limited diagnostic resources.